DETERMINATION OF THE BLOOD LIPIDE SPECTRUM IN PATIENTS WITH HEART ISCHEMIC DISEASE

Abstract

Ischemic heart disease (IHD) remains one of the leading causes of morbidity, disability, and mortality worldwide. Despite the achievements of modern cardiology, coronary artery atherosclerosis continues to determine the prognosis in this category of patients. The atherosclerotic process is based on lipid metabolism disorders, among which an increase in the level of atherogenic lipid fractions and a decrease in the content of high-density lipoproteins play a key role. Therefore, studying the lipid profile of the blood in coronary artery disease has not only diagnostic significance but also serves as a crucial tool for predicting cardiovascular risk.